- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vaxart Inc (VXRT)
Track today's live Vaxart (VXRT) share price, performance and key data on this page with our current OTC Markets:VXRT stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Vaxart share price on the OTC Markets exchange. Use the dropdown to switch exchange for the VXRT share price, head to our technical summary section, which provides analysis on Vaxart share price buy/sell indicators using real-time data (or discuss the Vaxart (VXRT) stock price today with other investors in the Vaxart OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:VXRT share price (ISIN: US92243A2006) to enhance your trading decisions with our free investment tools and resources.
What Is the Vaxart Inc Share Price Today?
The Vaxart share price today is 0.4400.
What Is the Stock Symbol for Vaxart Inc
The stock symbol (or 'ticker') for Vaxart Inc is "VXRT."
What Stock Exchange Does Vaxart Inc Trade On?
Vaxart Inc is listed and trades on the OTC Markets stock exchange.
Is Vaxart Inc a Good Stock to Buy?
Determining whether Vaxart (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:VXRT share price (ISIN: US92243A2006) to enhance your trading decisions with our free investment tools and resources.
What Is the Vaxart Inc Share Price Today?
The Vaxart share price today is 0.4400.
What Is the Stock Symbol for Vaxart Inc
The stock symbol (or 'ticker') for Vaxart Inc is "VXRT."
What Stock Exchange Does Vaxart Inc Trade On?
Vaxart Inc is listed and trades on the OTC Markets stock exchange.
Is Vaxart Inc a Good Stock to Buy?
Determining whether Vaxart (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4306
0.4623
52 wk Range
0.3050
0.8449
Unusual Pre-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.43060.4623
52 wk Range
0.30500.8449
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VXRT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
3.3333
Upside
+657.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.3333
(+657.58% Upside)
Vaxart Inc Earnings Call Summary for Q2/2026
- Vaxart missed Q2 2026 estimates with revenue of $27.2M (down 46% vs. forecast) and a 6-cent loss per share versus 3-cent expected loss.
- Revenue fell 31.5% YoY due to lower BARDA contract revenue; R&D spending dropped 32.2%, narrowing net loss to $13.5M from $15M prior year.
- Company holds $64M cash with runway into Q2 2027; BARDA released additional $29M for expanded COVID-19 trial analysis and completion.
- Main COVID-19 trial (5,000 participants) fully enrolled; top-line efficacy and safety data expected in first half of 2027 per management guidance.
- Shares fell 3.4% to $0.55; company pursuing non-dilutive funding including government contracts, partnerships, and $25M Lincoln Park facility.
Last Updated: 07/08/2026, 22:28
Read Full TranscriptEarnings
Latest Release
06/08/2026
EPS / Forecast
-0.06 / -0.03
Revenue / Forecast
27.19M / 50.5M
Compare VXRT to Peers and Sector
Metrics to compare | VXRT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVXRTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 2.8x | −2.1x | −0.4x | |
PEG Ratio | 0.02 | −0.07 | 0.00 | |
Price/Book | 1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 0.4x | 180.7x | 3.0x | |
Upside (Analyst Target) | - | 392.7% | 56.4% | |
Fair Value Upside | Unlock | 21.3% | 7.9% | Unlock |
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company’s product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Vaxart (OTC Markets: VXRT) Share Price Today?
The Vaxart stock price today is 0.4400 USD.
What Stock Exchange Does Vaxart (VXRT) Trade On?
Vaxart is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Vaxart?
The stock symbol (also called a 'ticker') for Vaxart is "VXRT."
What Is the Current Vaxart Market Capitalisation?
As of today, Vaxart (OTC Markets: VXRT) market cap is 107.0100M USD.
What Is Vaxart's (VXRT) Earnings Per Share (TTM)?
The Vaxart EPS is currently 0.1620 (Trailing Twelve Months).
When Is the Next Vaxart Earnings Date?
Vaxart's next earnings report will be released on 29/10/2026.
Is VXRT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Vaxart moving averages and other technical indicators, the daily buy/sell signal for VXRT stock is Strong Sell.
How Many Times Has Vaxart Stock Split?
Vaxart has split 2 times. (See the VXRT stock split history page for full effective split date and price information.)
How Many Employees Does Vaxart Have?
Vaxart has 65 employees, based on their latest Companies House report.
What is the current trading status of Vaxart (OTC Markets: VXRT)?
As of 02/10/2026, Vaxart (VXRT) is trading at a share price of 0.4400 USD, with a previous close of 0.4400 USD. The stock has fluctuated within a day range of 0.4306 USD to 0.4623 USD, while its 52-week range spans from 0.3050 USD to 0.8449 USD.
What Is Vaxart (VXRT) Price Target According to Analysts?
The average 12-month price target for Vaxart is 3.3333 USD, with a high estimate of 4 USD and a low estimate of 2 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +657.58% Upside potential.
What Is the VXRT Premarket Price?
VXRT's last pre-market stock price is 0.4951 USD. The pre-market share volume is 10.0000, and the stock has decreased by 0.0551, or 12.5200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.